Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...
Phathom Pharmaceuticals (NASDAQ:PHAT) traded higher on Friday after Cantor Fitzgerald initiated its coverage with an overweight recommendation despite a recent selloff attributed to the company's IP ...
Cantor Fitzgerald upgraded McEwen Mining (MUX) to Buy from Speculative Buy with an unchanged price target of $14.50 after the company completed ...
President Donald Trump’s nominee for U.S. Secretary of Commerce, Howard Lutnick, passed a key procedural vote in the Senate on Thursday, clearing the path for his final confirmation vote.
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...
Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Axsome Therapeutics in a note issued ...
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
“As you can imagine, the pain we suffered with Gary and 657 of my other friends and colleagues at Cantor Fitzgerald were killed on 9/11,” Lutnick said during his confirmation hearing before ...
Cantor Fitzgerald raised the firm’s price target on Protolabs (PRLB) to $50 from $40 and keeps an Overweight rating on the shares. Protolabs reported better-than-expected revenue and adjusted ...